Received Feb 11, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
reconstituted with a non-approved diluent a shot of PRIORIX; reconstituted with a non-approved diluent a shot of PRIORIX; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate dose of vaccine administered in a patient who received MMR (Priorix) for prophylaxis. On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced inappropriate dose of vaccine administered (Verbatim: reconstituted with a non-approved diluent a shot of PRIORIX) and wrong solution used in drug reconstitution (Verbatim: reconstituted with a non-approved diluent a shot of PRIORIX). The outcome of the inappropriate dose of vaccine administered and wrong solution used in drug reconstitution were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 09-FEB-2026 The medical assistant reported they reconstituted with a non approved diluent a shot of Priorix vaccine and wanted to know how to proceed and if revaccination was needed. The vaccine administration facility was the same as primary reporter. The batch number was not provided upon follow up with the reporter.